Member Info for Lawson

While I greatly admire a positive view. However, without news the sp will be mostly meaningless meanderings. I too have a positive view based on nothing other than my optimism that Iclaprim is a useful asset, both for the company and the medical world.

Great find. We will need an RNS to get things moving though.

All the blue I thought I could see must be an optical illusion then.

I can. Levity in adversity is better than crying into a bottle of the hard stuff.

It seems that there is lots of good news with this company. Solid tech, directors invested in the business and good sales so what does it take to wake the SP up?

Gareth, with respect, Connect bought Flybe back in January for 1p per share. That was bad for the share holders and made a lot of people very angry.

86DA, I think you have hit the nail squarely on the head, the only way is definitely without doubt up or down!

Good morning Scott. I trust you are well. I have copied this from your post from July 4.
“Unreal isn’t? Scandalous and I have the means to expose this state of affairs which I am about to employ “.
Would you care to elaborate?

I have bought today as at this low price and still hold from late February. Although it can still drop, I imagine it would be quite slowly so plenty of time to sell with a backstop.
However, Motif still owns Iclaprin and could feasibly sell it to a third party, maybe a Chinese Bio company..
It is a pure gamble but what stock isn't.
It's all a game but we play it just the same.

This is fun, in the words of the great Del Trotter, "Next year we'll be millionaires, except in this case it will be this week!!

Well now Kim, I had to give Google a good bashing to work that one out but now I finally get it! (A film) Iv'e Not seen it.
Definitely different to worrying about what those cads and bounders are up to at the FDA /Motif.

With respect Mug but are you completely out to lunch?
There is absolutely no rteason to suspend this at all.
If trading was suspended when waiting for important information there would be few shares trading at all.

I've only got this morning's 3 RNS. Can you paste it. Thanks

Liquid1 . It is possible that the delay is due to Motif already having the information but deciding on a suitable way to disseminate it. You would have thought they would have worked it out in advance but perhaps it is more complicated. Who knows!

Is that Levity Mr P? Surely not!!

Fair comment, I will hold,watch and wait.

Never posted on this forum until this very moment! I would have thought that a good news RNS would have woken this stock up, looking forward to some good news re the next payments.

I found it hard to believe as well and then I found this.
The NDA
The NDA (38) includes all data concerning the drug; all information about the manufacturing process and facilities, quality control, and assurance; a complete product description (chemical formula, specifications, pharmacodynamics, and pharmacokinetics); indications; labeling; and proposed risk evaluation and mitigation processes if applicable. A typical NDA can run 100,000 pages, and according to the Office of the Federal Register, the application fee in 2016 for an NDAe that requires clinical data is $2,374,200 39, 40. The FDA has 60 days to determin if they will file the application once it is received (41).

https://www.sciencedirect.com/science/article/pii/S2452302X1600036X

Unless we have all gone through a temporal distortion in the fabric of time, i Think that you are wrong. No big deal though.! Have a nice day.

Here's a theory in amongst the already multitude of theories.

If theyhad the FDA results on Friday and it was option 3, it would be pointless withholding the information and that goes for Monday after Midday as well. (5 hour time difference)

If we hear nothing, then perhaps it is good news as they will be finalising the plan for how they are going to market Iclaprim so there may be a small delay.

Just a thought while I wait for the rain to stop while trying to weed my jungle of a garden!